UgHerald provides the most timely and comprehensive news coverage of Uganda. It covers a wide range of fields including politics, economy, society, culture, sports, as well as in-depth analysis of international relations and important domestic events. Whether you are concerned about local developments or international influences, this is the best source for the latest information on Uganda. We are committed to helping readers understand the current situation and future of Uganda through accurate, objective and in-depth news reports, while paying attention to the challenges and development opportunities it faces.

About Us

tanzania times : Latest News and In-depth Analysis
Contact Us

Wildlife

HomeWildlife

All News

Feb 10, 2025

Info-Tech Research Group Highlights Key Infrastructure & Operations Priorities for 2025 in Latest Report

Info-Tech Research Group,a global leader in IT research and advisory,has unveiled its Infrastructure and Operations Priorities 2025 report,highlighting essential strategies for I&O leaders to navi

Feb 7, 2025

TRILLER PUTS CREATORS FIRST AS IT UNLEASHES THE FUTURE OF TECH, MUSIC & CULTURE WITH THE LATEST VERSION OF ITS APP

Powered by next-generation technology and with data privacy front and center,Triller is redefining the creator economy with new ways for brands and creators to own their content,connect with their fa

Feb 7, 2025

Global Times: Observing China's He Culture through the lens of Spring Festival

BEIJING,Feb. 6,2025-- TheQingcheng Palace complex at the Xiannongtan Temple,a gem along Beijing Central Axis,is the first ancient palace complex that was revitalized and unveiled after the Beijing Cen

Feb 7, 2025

Channel Factory partners with Dentsu Japan International Brands to drive unmatched media efficiency for YouTube campaign

SINGAPORE,Feb. 5,2025--Dentsu Japan International Brands Inc. (DJIB),the leading agency in the Japanese advertising market,has partnered with Channel Factory,a specialist in contextual targeting and m

Feb 7, 2025

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

HONG KONG,Feb. 6,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/

Feb 7, 2025

ADNOC Gas Delivers Record $5 Billion Net Income For 2024, Propelling Sustainable Growth Ambitions

$8.65 billion EBITDA for full year 2024,sees a rise of 14% year-on-year (YoY) Full year 2024 dividend of $3.41 billion confirmed,growing by 5% per annum

1 ... 67 68 69 70 71 72 73 ... 101